Rheumatology Network Newsletter

To view this email as a web page, click here.

Cancer link disproven, high fracture risk and more news from Rheumatology Network

In this slideshow, we revisit some of the most notable research findings in rheumatology that we featured in recent weeks. We begin with a study that shows TNF inhibitor treatment may not heighten cancer risk.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.